What
  • Delivery Company
  • Subscription Service
  • Supply Chain Management
  • Coffee Shops
  • Mail Order Marijuana (M.O.M)
  • Cafe & Lounges
  • 420 Friendly Lodging
  • Accounting Firms
  • Advertising Agencies
  • Apparel Companies
  • Banking
  • Banking & Payment Processing
  • Brands
  • Business Directory
  • Cannabis Conferences
  • Cannabis Infused Companies
  • Cannabis Lawyers
  • Capital Loans
  • CBD Products
  • Consulting Services
  • Co-Working Space
  • Cultivatiors and Growers
  • Delivery
  • Dispensary
  • Distribution Services
  • E-Commerce
  • Edibles
  • Entrepreneur
  • Education
  • Extraction Company
  • Event Companies
  • Cannabis Events
  • Head Shop
  • Hemp Products
  • Home Grow
  • Hydroponics & Cultivation Products
  • Influencers
  • Information
  • Insurance Providers
  • Investors
  • Job Forums
  • Legal Resources
  • Licensed Producer
  • Manufacturing & Equipment
  • Marketplace
  • Marketing Agency
  • Media
  • Medical Clinic
  • Online Store
  • Organizations
  • Packaging & Supplies
  • Political Organizations
  • Private Equity & Investment Resources
  • Products
  • Public Relations
  • Publications
  • Real Estate
  • Real Estate Services
  • Research and Development
  • Retail Stores
  • Seed Banks
  • Software
  • Security Services and Equipment
  • Storage
  • Staffing and Recruitment
  • Technology Company
  • Testing & Lab Services
  • Tourism and Travel
  • Transportation
  • Training and Education
  • Vaporizer Companies
  • Wholesale
  • Main Feature
Where
MedCan 2020
18 Mar

MedCan 2020

Hosted by: BioTech New Zealand

Share :
  • SkyCity Auckland Convention Centre Federal Street, Auckland CBD, Auckland, New Zealand

    Get Direction
  • 8:00 AM - Wednesday

    March 18, 2020

About the event

The purpose of MedCan 2020 is to educate and enable the New Zealand medicinal cannabis sector. We want to ensure that New Zealanders are equipped to maximise the opportunities that medicinal cannabis brings – improving quality of life and fuelling economic growth. MedCan 2020 will bring together leading experts, scientists, clinicians, entrepreneurs, investors, policy makers and thought leaders to share first-hand insights and up-to-date information about the world of medicinal cannabis. The summit has been created to inspire and inform:
  • Healthcare professionals
  • Academics
  • Researchers
  • Government officials
  • Business
  • Investors
  • Entrepreneurs and innovators
  • Growers
  • Patients
Disclaimer: The scope of MedCan 2020 Summit is limited to the Medicinal Cannabis sector and does not include the “adult or recreational use” issue. The objectives of the summit are to:
  • Bring together leading experts, scientists, clinicians, entrepreneurs, investors, policy makers and thought leaders to gain first-hand, expert and up to date information about the world of medicinal cannabis.
  • Create discussions to ensure robust understanding of the complex science and medical benefits for patients.
  • Gain insights into the future of the industry for local and global markets.
  • Foster networking and collaboration, nationally and internationally.
  • Learn from the many years of experience from other countries.
This event will play a significant role in the aggregation of knowledge, to ensure a solid foundation of scientific understanding of cannabis for the advancement of public policy, and the nation’s overall public health. New Zealand is keen for industry to understand the challenges and opportunities within this complex and dynamic ecosystem.

Audience

Healthcare professionals will receive accredited education covering everything from prescribing and dispensing medicinal cannabis, to the current body of evidence and safety considerations. Science, technology and industry stakeholders will learn about the business of cannabis, world markets, new technologies, and international research. Patients will discover how cannabis is being used to treat many different conditions, and how products are accessed in New Zealand.

Speakers

Learn from leading international and national thought leaders on everything from seed to sale, clinical trials, prescribing, patient case studies as well as the social, cultural and economic benefits to New Zealand. Explore the content through the core pillars of medicinescienceindustry and technology to further understand the complexity of cannabis as a medicine. “It is an exciting time in New Zealand for medicinal cannabis and I am delighted to be part of MedCan 2020 to ensure that the scientific knowledge is disseminated to patients, practitioners, scientists and industry on the benefits of medicinal cannabis” Professor Raphael Mechoulam, PhD, Professor at Hebrew University of Jerusalem. (Video keynote address)
  • Professor Raphael Mechoulam, PhD - Professor at Hebrew University of Jerusalem
  • Dr David Hepburn, MD - Medical Director, Plena Global
  • Dr Maria-Fernanda Arboleda, MD - International Director Medical Services, Khiron Life Sciences Corp
  • Dr. Adele Hosseini - Chief Scientific Officer, Bod Australia
  • Dr Jason Wargent, PhD - Founder & CSO, Biolumic
  • Paul Mavor - Pharmacist, Health House International
  • Dr Kevin Spelman, PhD - Molecular Biologist, Phytochemist and Clinician
  • Sharlene Mavor - Medical Scientist, Medical Cannabis Research Australia
  • Brent Zettl - President and CEO, ZYUS Life Sciences Inc.
  • Ido Kanyon - CEO, AusCann
  • Dr Graham Gulbransen, FRNZCGP, FAChAM - Cannabis Consultant, GP and Addiction Specialist
  • Dr Giresh Kanji, MbCHb, PhD - Musculoskeletal Pain Specialist
  • Dr Rick Acland MbCHb, FAFRM (RACP) - Rehabilitation Specialist, Christchurch
  • Dr Liza Schneider, BVSc - Director / Veterinarian, Holistic Vets
  • Dr Jo Nunnerley - Academy Director, Burwood Academy of Independent Living (BAIL)
  • Dr Richard Newcomb, PhD - Chief Scientist, Plant & Food Research
  • Dr Amy Fletcher, PhD - Associate Professor of Political Science and IR, The University of Canterbury
  • Dr James Polston, PhD - Chief Science Officer, Helius Therapeutics
  • Dr Samuel Banister, PhD - Team Leader in Medicinal Chemistry, The University of Sydney
  • Dr Stephen Tallon, PhD - Team Leader, Process Engineering Group, Callaghan Innovation
  • Dr Geoff Noller, PhD - Research Consultant, Substance Use and Policy Analysis
  • Rhys Cohen - Principal Consultant, FreshLeaf Analytics
  • Martin Woodbridge - International Consultant, Woodbridge Research
  • Katy Thomas - TV Presenter. Editor. Mother and overnight Influencer.
  • Lanai Carter
  • Simon Carson - Medical Director, Southern Clinical Trials Group Ltd
 

Pre-Summit Programme

  • 09:00 - 12:00
    • New Zealand Government - Understand the current position
      • Understand the current position from New Zealand Government agencies regarding medicinal cannabis as an economic growth opportunity
  • 13:00 - 17:00
    • Soil to sale - Meet and discuss with industry along the supply chain
  • 13:00 - 17:00
    • Clinical trials - The potential role of the New Zealand clinical trial sector to play on the global stage
  • 13:00 - 17:00
    • Building a viable cannabis business - Understand additional opportunities for New Zealand businesses

Main Summit Programme

  • 08:00 - 08:30         
      • Registration opens
  • 08:30 - 08:40             
      • Karakia and official opening
  • 08:40 - 08:50
      • Welcome
  • 08:50 - 09:00           
  • 09:00 - 09:50       
      •  Keynote: The history of cannabis as a medicine - video keynote address
  • 09:50 - 10:15             
      • Keynote: Understanding the pharmacology of medicinal plants
  • 10:15 - 10:55   
      •   Morning tea, exhibition and networking
  • 11:00 - 11:25
      •    The Medicinal Cannabis Scheme: Industry regulations
  • 11:00 - 11:25   
  • 11:00 - 11:25    
  • 11:25 - 11:50    
      • New Zealand - shaping a world-class medicinal cannabis programme
  • 11:25 - 11:50   
      • The chemistry and pharmacology of cannabis
  • 11:25 - 11:50    
      • Five areas in medicine where cannabis should be considered
  • 11:50 - 12:15 
      • Current evidence and practical experience for cannabinoid-based medicines in chronic pain and palliative care management
  • 11:50 - 12:15
      •   Natural product scaffolds for the development of new drugs
  • 12:15 - 12:40
  • 12:15 - 12:40
      • An unexpected journey, from biotech to cannabis medicine and back again
  • 12:15 - 12:40
      • Panel discussion: product development, quality and testing
  • 12:40 - 13:40
      • Lunch, exhibition and networking
  • 13:40 - 14:05
  • 13:40 - 14:05
      • Medicinal cannabis from a grower’s perspective
  • 13:40 - 14:05
      • Dispelling the myths of THC
  • 14:05 - 14:30 
      • The NZ regulatory environment, and implications for prescribers and patients
  • 14:05 - 14:30
      • Extraction of cannabis: Options, current industrial practice, and future trends
  • 14:05 - 14:30
      • Regulatory and scientific rigor in medicinal cannabis
  • 14:30 - 14:55
      • Protecting your intellectual property, opportunities and risk
  • 14:30 - 14:55
      • Case studies of medicinal cannabis clinical trials
  • 14:30 - 14:55
      • Setting up your facility and Product development
  • 14:30 - 14:55
      • Case studies of the use of medical cannabis in New Zealand
  • 14:55 - 15:20
      • The data collection systems NZ & Australia
  • 14:55 - 15:20
      • Pharmaceutical cannabis for healthcare professionals
        • By Paul Mavor Pharmacist, Health House International
  • 15:20 - 15:50
      • Afternoon tea, exhibition and networking
  • 15:50 - 16:20
      • Panel Discussion: Patients perspective
  • 16:20 - 16:50
      • Panel discussion: Disruptive technologies
      • The role of technology in the medicinal cannabis sector – artificial intelligence, big data, blockchain, synthetics
  • 16:50 - 17:00
      • Closing remarks
  • 17:00 - 18:30
      • Drinks reception & networking

    Attendees (0)

      Are You going ?0 going
      Get Tickets